ProShares UltraShort Health Care (NYSEARCA:RXD – Get Free Report) was the recipient of a significant decline in short interest in the month of August. As of August 14th, there was short interest totaling 709 shares, a decline of 87.4% from the July 30th total of 5,647 shares. Based on an average trading volume of 5,098 shares, the short-interest ratio is presently 0.1 days. Currently, 0.4% of the shares of the company are sold short.
Institutional Trading of ProShares UltraShort Health Care
An institutional investor recently bought a new stake in ProShares UltraShort Health Care stock. IMC Chicago LLC acquired a new position in shares of ProShares UltraShort Health Care (NYSEARCA:RXD – Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 20,581 shares of the company’s stock, valued at approximately $209,000. IMC Chicago LLC owned about 4.29% of ProShares UltraShort Health Care at the end of the most recent quarter.
ProShares UltraShort Health Care Stock Performance
Shares of RXD traded up $0.33 on Thursday, reaching $14.51. 15,751 shares of the stock traded hands, compared to its average volume of 7,588. The stock’s 50-day moving average price is $16.19 and its 200-day moving average price is $18.31. ProShares UltraShort Health Care has a 12 month low of $13.78 and a 12 month high of $24.43.
About ProShares UltraShort Health Care
ProShares UltraShort Health Care (the Fund) seeks daily investment results that correspond to twice (200%) the inverse (opposite) of the daily performance of the Dow Jones U.S. Health Care Index (the Index). The Fund intends to invest at least 80% of its net assets, including any borrowings for investment purposes, to investments that, in combination, have economic characteristics that are inverse to those of the Index. The Fund also intends to invest assets not invested in financial instruments, in debt instruments and/or money market instruments.
See Also
- Five stocks we like better than ProShares UltraShort Health Care
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for ProShares UltraShort Health Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares UltraShort Health Care and related companies with MarketBeat.com's FREE daily email newsletter.
